2013•The Veterinary JournalRequires access

The proteasome inhibitor bortezomib inhibits the growth of canine malignant melanoma cells in vitro and in vivo

Keita Ito, Masato Kobayashi, Shiori Kuroki, Yu F. Sasaki, Taisuke Iwata, Kohei Mori, Tetsuya Kuroki, Yuta Ozawa, Masanori Tetsuka, Tomoko Nakagawa, Teruyo Hiroi, Hitomi Yamamoto, Kenichiro Ono, Tsukimi Washizu, Makoto Bonkobara

Open publisher page 21 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 21 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Bortezomib, Proteasome inhibitor, Melanoma, Cancer research, In vivo, Cell growth, Cell culture, Proteasome

Related papers

Back to paper searchBrowse research topicsOriginal source
The proteasome inhibitor bortezomib inhibits the growth of canine malignant melanoma cells in vitro and in vivo — Research Paper | ScholarLens